Beacon Pointe Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Sell |
4,316
-2,847
| -40% | -$157K | ﹤0.01% | 1121 |
|
|
2025
Q1 | $506K | Buy |
7,163
+1,399
| +24% | +$98.9K | 0.01% | 833 |
|
|
2024
Q4 | $379K | Sell |
5,764
-4,906
| -46% | -$322K | ﹤0.01% | 914 |
|
|
2024
Q3 | $750K | Buy |
10,670
+526
| +5% | +$37K | 0.01% | 708 |
|
|
2024
Q2 | $835K | Sell |
10,144
-4,466
| -31% | -$368K | 0.01% | 693 |
|
|
2024
Q1 | $1.28M | Sell |
14,610
-3,228
| -18% | -$282K | 0.01% | 612 |
|
|
2023
Q4 | $1.72M | Sell |
17,838
-133
| -0.7% | -$12.8K | 0.02% | 513 |
|
|
2023
Q3 | $1.59M | Sell |
17,971
-356
| -2% | -$31.5K | 0.02% | 512 |
|
|
2023
Q2 | $1.59M | Sell |
18,327
-729
| -4% | -$63.2K | 0.03% | 415 |
|
|
2023
Q1 | $1.85M | Buy |
19,056
+1,372
| +8% | +$133K | 0.03% | 414 |
|
|
2022
Q4 | $1.83M | Buy |
17,684
+2,645
| +18% | +$274K | 0.04% | 374 |
|
|
2022
Q3 | $1.27M | Sell |
15,039
-253
| -2% | -$21.4K | 0.03% | 414 |
|
|
2022
Q2 | $1.27M | Sell |
15,292
-1,125
| -7% | -$93.1K | 0.03% | 416 |
|
|
2022
Q1 | $1.27M | Buy |
16,417
+1,499
| +10% | +$116K | 0.02% | 553 |
|
|
2021
Q4 | $1.32M | Sell |
14,918
-1,764
| -11% | -$156K | 0.03% | 328 |
|
|
2021
Q3 | $1.29M | Buy |
16,682
+9,260
| +125% | +$716K | 0.03% | 369 |
|
|
2021
Q2 | $619K | Buy |
+7,422
| New | +$619K | 0.02% | 433 |
|